Nuvectis Pharma, Inc. (NVCT)
23.87
+0.31
(+1.32%)
USD |
NASDAQ |
Aug 24, 16:00
23.86
-0.01
(-0.04%)
Pre-Market: 20:00
Nuvectis Pharma Shareholders Equity (Quarterly) : 9.082M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.082M |
| March 31, 2026 | 14.22M |
| December 31, 2025 | 18.41M |
| September 30, 2025 | 24.01M |
| June 30, 2025 | 16.87M |
| March 31, 2025 | 20.95M |
| December 31, 2024 | 9.713M |
| September 30, 2024 | 10.99M |
| June 30, 2024 | 12.53M |
| March 31, 2024 | 14.02M |
| December 31, 2023 | 12.20M |
| Date | Value |
|---|---|
| September 30, 2023 | 16.69M |
| June 30, 2023 | 20.33M |
| March 31, 2023 | 12.27M |
| December 31, 2022 | 14.22M |
| September 30, 2022 | 20.37M |
| June 30, 2022 | 11.50M |
| March 31, 2022 | 14.56M |
| December 31, 2021 | 4.238M |
| September 30, 2021 | 6.314M |
| June 30, 2021 | 6.825M |
| March 31, 2021 | -0.033M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Decoy Therapeutics, Inc. | 4.321M |
| Unicycive Therapeutics, Inc. | 53.27M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.38M |
| Total Liabilities (Quarterly) | 13.29M |
| Current Ratio | 1.683 |